MIRA Pharmaceuticals, Inc.
corporate_fare Company Profile
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for MIRA at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Ketamir-2 Results; DEA Confirms Not Controlled Substance
- MIRA Pharmaceuticals Publishes Positive Preclinical Data for Obesity/Nicotine Drug SKNY-1
- MIRA Pharmaceuticals Reports Going Concern Warning, Significant Losses, and Highly Dilutive Acquisition
- Mira-55 Shows No CNS Side Effects in Preclinical Studies, Advancing IND Submission
- MIRA Pharmaceuticals Completes Phase 1 Dosing for Ketamir-2 with Favorable Safety Profile
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$10.44M
Diluted EPS
-$1.35
Op. Cash Flow
-$4.66M
Cash & Equivalents
$6.35M
Debt / Equity
0.00×
Shares Outstanding
41.94M sh
Source: 10-K · filed 2026-03-31 · accession 0001493152-26-014001
show_chartPrice Chart
Loading chart...
feed MIRA - Filings & News (Page 2)
MIRA
May 13, 2026, 4:01 PM EDT
Price at Filing:
$0.9747
Real-time Price:
$0.297
Change:
-$0.6777 (-70%)
Market Cap:
$12.228M
MIRA
May 13, 2026, 7:30 AM EDT
Price at Filing:
$0.980
Real-time Price:
$0.297
Change:
-$0.683 (-70%)
Market Cap:
$12.228M
MIRA
Mar 31, 2026, 2:02 PM EDT
Price at Filing:
$1.07
Real-time Price:
$0.297
Change:
-$0.773 (-72%)
Market Cap:
$12.228M
MIRA
Mar 23, 2026, 9:00 AM EDT
Price at Filing:
$0.9785
Real-time Price:
$0.297
Change:
-$0.6815 (-70%)
Market Cap:
$12.228M
MIRA
Mar 03, 2026, 4:01 PM EST
Price at Filing:
$1.24
Real-time Price:
$0.297
Change:
-$0.943 (-76%)
Market Cap:
$12.228M
MIRA
Feb 17, 2026, 8:30 PM EST
Price at Filing:
$1.21
Real-time Price:
$0.297
Change:
-$0.913 (-75%)
Market Cap:
$12.228M
MIRA
Feb 02, 2026, 4:01 PM EST
Price at Filing:
$1.19
Real-time Price:
$0.297
Change:
-$0.893 (-75%)
Market Cap:
$12.228M